Introduction {#Sec1}
============

Intestinal malrotation (IM) is refers to all abnormalities of intestinal position and attachment and includes the concept of atypical malrotation or malrotation variant \[[@CR1]\]. It is often accompanied by a narrow base of the small bowel mesentery. The incidence of IM is 1:500--1:3,500 living births \[[@CR2], [@CR3]\]. Volvulus, a rotation of the gut along its mesenteric stalk occurs in 60--70% of neonates diagnosed with IM, the ultimate strangulation in about 15% \[[@CR4]\]. Eighty percent of the patients with symptomatic IM present in their first month of life \[[@CR5]\] and require surgery. Delay in diagnosis may lead to intestinal ischemia, intestinal necrosis, septicaemia and short bowel syndrome. The surgical outcome is negatively influenced by the presence of intestinal necrosis \[[@CR6]\], and the need for operation during the first 3 months of life \[[@CR6]--[@CR9]\]. To keep mortality and morbidity low, all asymptomatic children with intestinal malrotation are advised to undergo semi-elective surgery (Ladd's procedure) in childhood and adolescence \[[@CR10], [@CR11]\].

Intestinal malrotation has been described in almost 100 syndromes and combinations. Associated serious abnormalities increase the mortality risk in patients with IM of about 22-fold according to Messineo \[[@CR6]\]. Commonly associated congenital malformations are duodenal atresia, abdominal wall defects or diaphragmatic hernia \[[@CR3], [@CR12]\]. It is more frequently observed in patients with situs inversus \[[@CR13]\] or heterotaxia, a syndrome associated by congenital cardiovascular defects \[[@CR14]\].

Congenital cardiovascular defects (CCVD) are among the most common congenital birth defects occurring in about 1 in 100 living births \[[@CR15]\]. Congenital malformations of the gastrointestinal, musculoskeletal and urinary systems are the most frequently seen extra cardiac malformations in patients with CCVD \[[@CR16]\]. Intestinal malrotation has been observed in 2.8--4.1% of all the patients with CCVD, mainly in patients with single ventricle \[[@CR17]\]. However, the incidence of CCVD in IM patients has not been precisely quantified in the recent literature and the full array of the associated cardiac anomalies has not been well described.

The purpose of our study was (1) to delineate and accurately describe the types and incidence of associated cardiac lesions in our most recent 25-year experience of patients with IM, and (2) to study the influence of a co-existing CCVDs on IM surgery morbidity and mortality.

Materials and methods {#Sec2}
=====================

Population {#Sec3}
----------

A retrospective review at a single university centre was conducted on all the paediatric patients diagnosed with IM born and between September 1980 and September 2005. Patients with CCVD were identified for further analysis. Patients demographics recorded included gestational age, weight and gender. Data on the type of CCVD, other congenital defects, known syndromes or associations, post-operative complications, morbidity and mortality were collected. The diagnosis of CCVD was based on clinical, ECG, echocardiography, heart catheterization and peri-operative findings. The IM diagnosis was based on radiological upper gastro-intestinal examination, or during acute surgery.

Data analysis {#Sec4}
-------------

Collected data were analyzed by calculating prevalence percentages. Analysis of nominal variables was performed using cross tables for calculating relative risk (RR) with the corresponding 95% confidence interval (95% CI). Fisher extact test was used for comparison of percentages of both CCVD groups, expressed as *P* values. For the comparison of continuous variables, Mann--Whitney *U* test was used to calculate *P* value. The *P* values are two-sided, and a value of *P *= 0.05 was considered statistical significant. For the calculation of risk factors for both post-operative morbidity and mortality, (adjusted) odds ratios (OR) with consequent 95% CI were calculated by uni- and multi-variate regression analysis. Statistical analysis was performed using SPSS software (version 12.0.1; SPSS Inc., Chicago, IL, USA).

Results {#Sec5}
=======

Demographics {#Sec6}
------------

During a period of 25 years, 284 patients were diagnosed in our centre with IM. Ninety-three of the 284 patients were identified with CCVD as well. Fifteen patients had persistent pulmonary hypertension (PPHT), all but one with congenital diaphragmatic hernia. One patient had a solitary pre-duodenal portal vein. The records of these 16 patients without structural CCVD were excluded, leaving 77 patients with both IM and CCVD (27.1% of the total IM population in the last 25 years) for further analysis. The gestational age range was 26--42 weeks with a median of 39 weeks. Median birth weight was 2.86 kg (range 0.72--4.53). A female predominance was seen with 47 girls (61%) and 30 boys (39%). Median follow-up period after IM diagnosis was 2.8 years (range 0--24 years). The overall survival at the end of follow-up was 80.5% (15 out of 77 patients died).

Congenital cardiovascular defects {#Sec7}
---------------------------------

The CCVDs were divided into the subgroups, major and minor CCVDs (see Table [1](#Tab1){ref-type="table"}), varying from small ventricular septal defect (VSD) to common arterial trunk (CAT). Thirty-seven out of 77 patients (48.1%) were diagnosed with major CCVD and 40 patients (51.9%) with minor CCVD. Table 1Types of major and minor congenital cardiovascular defectsMajor CCVD*n* = 37 (100%)Minor CCVD*n* = 40 (100%)Complex cardiovascular defects*n* = 18 (48.6%)Ventricular septal defect*n* = 16 (40.0%)Tetralogy of Fallot*n* = 7 (18.9%)Atrium septal defect*n* = 7 (17.5%)Hypoplastic left heart syndrome*n* = 3 (8.1%)Peripheral pulmonary stenosis*n* = 4 (10.0%)Atrioventricular septal defect*n* = 3 (8.1%)Persistent ductus arteriosus*n* = 3 (7.5%)Pulmonary valve atresia*n* = 1 (2.7%)Pulmonary valve stenosis*n* = 3 (7.5%)Transposition of the great arteries*n* = 1 (2.7%)Aortic valve stenosis*n* = 2 (5.0%)Tricuspid valve atresia*n* = 1 (2.7%)Aortic coarctation*n* = 1 (2.5%)Common arterial trunk*n* = 1 (2.7%)Hypertrophic cardiomyopathy*n* = 1 (2.5%)Aortic arch hypoplasia*n* = 1 (2.7%)Subvalvular aortic valve stenosis*n* = 1 (2.5%)Dextrocardia*n* = 1 (2.7%)Left superior caval vein*n* = 1 (2.5%)Arteria lusoria*n* = 1 (2.5%)*CCVD*Congenital cardiovascular defects

The characteristics of the whole group (*n* = 77) as well as that of the subgroups are described in Table [2](#Tab2){ref-type="table"}. Forty-two patients underwent cardiac surgery, of which 20 patients had two or more cardiac surgical interventions. Patients with major CCVDs needed cardiac surgery more often. Minor CCVDs that needed surgical intervention most frequent were VSD, atrial septal defects (ASD) and aortic valve stenosis (AS). Six patients with severe CCVD did not undergo correction of their heart disease before IM operation: three patients died (*n* = 2 due to post IM surgery complications, *n* = 1 because of other congenital malformations). One patient with dextrocardia did not need cardiac correction. The two patients with Tetralogy of Fallot (TOF) underwent cardiac correction 6 months after IM surgery. Table 2Characteristics of studied population and its subgroups of congenital cardiovascular defectsCharacteristicAll CCVDMajor CCVDMinor CCVDRelative risk (95% CI)/*P*value100% *(n* = 77)100% (*n* = 37)100% (*n* = 40)Boys39% *(n* = 30)35.1% *(n* = 13)42.5% *(n* = 17)0.85 (0.5--1.4)Syndromes or associations53.2% (*n* = 41)67.6% *(n* = 25)40% *(n* = 16)**1.8 (1.1--3.1)**Other congenital defects84.4% *(n* = 65)83.8% *(n* = 31)85% *(n* = 34)0.95 (0.5--1.8)Cardiac surgery54.4% *(n* = 42)83.8% *(n* = 31)27.5% (*n* = 11)**4.3 (2.0--9.1)**CCVD diagnosed before IM57.1% *(n* = 44)78.4% *(n* = 29)37.5% *(n* = 15)**2.7 (1.4--5.2)**Age at CCVD diagnosis in days \[median (range)\]4.5 (0--210)4 (0--98)7 (0--210)*P* = 0.12Birth weight in kilograms \[median (range)\]2.86 (0.72--4.53)2.96 (0.96--4.53)2.84 (0.72--4.30)*P* = 0.4Age at first CCVD surgery in days \[median (range)\]102 (2--3,759)43 (2--3,759)117 (24--1,705)*P* = 0.15Values in bold represent statistical significant results*CCVD*Congenital cardiovascular defects, *IM*Intestinal malrotation

Congenital malformations, syndromes and associations {#Sec8}
----------------------------------------------------

Congenital malformations other than IM and CCVD were observed in 65 of the 77 (84.4%) patients, see also Table [2](#Tab2){ref-type="table"}. Most frequently observed congenital malformations included omphalocele (*n* = 7), congenital diaphragmatic hernia (*n* = 7), ano-rectal malformations (*n* = 6) and heterotaxia (*n* = 6).

Syndromes and associations were recognized in 41 (53.2%) patients, of which Down syndrome (*n* = 7), heterotaxia (*n* = 6), VACTERL (*n* = 5), Ivemark (*n* = 5) and lateralization abnormalities (*n* = 4) were most frequently recognized. Kartagener syndrome occurred in two patients. Several other syndromes all occurred once. Syndromes and associations were more frequent in patients with major CCVD.

Intestinal malrotation surgery {#Sec9}
------------------------------

Characteristics of IM-operated patients and their major and minor CCVD subgroups are described in Table [3](#Tab3){ref-type="table"}. Five patients did not undergo IM surgery yet; in three patients the surgery was about to take place in the near future, in one patient no surgical intervention was planned and one patient died of an unknown cause before IM surgery could take place. A Ladd procedure was performed for IM correction. Twenty-eight out of the 72 operated patients needed acute IM surgery, at a median age of 4.0 days (range 0--455). Only 4 out of these 28 patients had previously undergone surgical correction of the CCVD. Five patients had ischemic bowel disease at time of acute IM intervention; three of these patients died, one due to massive intestinal necrosis (one patient died due to cardiovascular cause, one patient died because of severe infection). At the time of IM surgery, signs and symptoms of CCVD, e.g., hepatomegaly, central cyanosis, cardiac murmurs and respiratory insufficiency, were more often observed twice in patients with a major CCVD (62.2 vs. 30.0%, respectively, *P* = 0.004). Most common complications were intestinal (Platzbauch, leakage of the bowel anastomosis resulting in sepsis, feeding difficulties with long-term necessity of nasogastrical tube feeding), infections and cardiovascular complications (e.g. bradycardia, thrombosis, arrhythmia) and they did not differ between both subgroups. Thirteen patients needed relaparotomy because of leakage of the bowel anastomosis (*n* = 4), Platzbauch (*n* = 2), suspected bowel obstruction with feeding difficulties (*n* = 1) and necrotising enterocolitis (*n* = 1). Five patients were reoperated for an adhesion ileus, all but one more than 1 month after surgery. Table 3Characteristics of general population, major and minor congenital cardiovascular defects groups operated on intestinal malrotationCharacteristicAll CCVDMajor CCVDMinor CCVD*P*valueIM surgery100% *(n* = 72)100% *(n* = 34)100% *(n* = 38)−Physical signs CCVD prior to IM surgery48.6% *(n* = 35)67.6% *(n* = 23)30.0% *(n* = 12)**0.004**Post-IM-operative complications61.1% *(n* = 44)67.6% *(n* = 23)55.3% *(n* = 21)0.3Post-IM-operative cardiovascular complications18.1% *(n* = 13)20.6% *(n* = 7)15.8% *(n* = 6)0.8Relaparotomy18.1% *(n* = 13)17.6% *(n* = 6)18.4% *(n* = 7)1.0Age at IM surgery in days \[median (range)\]17 (0--1,293)104 (0--1,196)6 (0--1,293)**0.006**Weight at IM surgery in kilograms \[median (range)\]3.21 (1.20--11.4)4.84 (1.20--11.4)2.88 (1.24--10.6)**0.02**Death in days after IM surgery \[median (range)\]28 (0--1,814)33 (0--1,814)3 (3--59)0.2Age at death in days \[median (range)\]40.5 (3--3,010)46 (22--3,010)8 (3--60)0.1Values in bold represent statistical significant results*CCVD*Congenital cardiovascular defects, *IM*Intestinal malrotation

Patients suffering from a post-operative IM surgery complication were younger (5.5 vs. 94.5 days, *P* = 0.031) and had a lower body weight (2.86 vs. 4.84 kg, *P* = 0.003) at time of IM surgery. Major CCVD, co-occurrence of a syndrome, or other congenital malformations did not significantly increase the risk on post-IM-operative morbidity. Correction for age and weight at the time of IM surgery in both CCVD groups showed, although not significant, a clear trend in post-IM-operative morbidity risk in patients diagnosed major CCVD (OR 2.9, 95% CI 0.9--9.6). Patients with pre-operative signs of CCVD had a four times increased risk on post-operative complications (95% CI 1.4--11.0). This risk factor was more prominent after correction for age and weight at the time of IM surgery (OR 8.2, 95% CI 2.1--30.7).

Mortality {#Sec10}
---------

Fifteen (19.5%) out of 77 patients died, 9 with major CCVDs. One patient with a minor CCVD died prior to IM surgery at the age of 1.4 years; cause of death remained unclear. Known causes of death after IM surgery were: cardiovascular complications (*n* = 7), massive intestinal necrosis (*n* = 2), sepsis (*n* = 2), respiratory failure (*n* = 2) and abstention of medical care because of unsuccessful surgical intervention on malformed trachea (*n* = 1). In both CCVD groups, death due to a cardiovascular cause remained the most frequent one. Median age at time of death was 40.5 days (range 3--3,010), with a median of 28.5 days after IM surgery (range 0--1,814). Of the 14 deceased patients, 9 (64.3%) had a major CCVD. Median age at time of death in the major CCVD group was 46 days (range 22--3,010) and in the minor CCVD group 8 days (range 3--60 days), although this difference was statistically not significant (*P* = 0.4). Twenty percent of the patients (7/35) with pre-operative physical signs of CCVD died, only one due to a cardiovascular cause. Three out of five patients with ischemic bowel at the time of IM surgery died post-operatively. The risk factors for mortality are shown in Table [4](#Tab4){ref-type="table"}. Table 4Risk factors (expressed as odds ratios and 95% confidence interval) for mortality in the whole study population (*n* = 77)CharacteristicDeceasedAliveOdds ratio (95% CI)Adjusting for weight and age at time of IM surgery OR (95% CI)Major CCVD9281.8 (0.6--5.7)**5.0 (1.2--20.7)**Minor CCVD634Syndrome/association7340.7 (0.2--2.2)1.0 (0.3--3.4)No syndrome or association828Other congenital defects13521.3 (0.2--6.4)1.1 (0.2--5.9)No other congenital defects210Physical CCVD signs prior to IM-surgery7281.1 (0.3--3.4)1.3 (0.4--4.4)No physical CCVD signs prior to IM-surgery730Intestinal ischemia32**7.6 (1.1--51.2)**5.9 (0.9--42.4)No intestinal ischemia1156Post-IM-operative complications127**11.3 (1.4--92.3)8.7 (1.0--75.7)**No post-IM-operative complications1331Post-IM operative cardiovascular complications76**5.5 (1.5--20.5)4.5 (1.1--18.4)**No post-IM-operative cardiovascular complications851Values in bold represent statistical significant results*CCVD*Congenital cardiovascular defects, *IM*Intestinal malrotation

Discussion {#Sec11}
==========

This study addresses the co-existence of malrotation with different types of congenital cardiovascular defects. We found 27.1% of all the patients registered in the last 25 years for IM to have a major or minor CCVD. Major CCVDs were seen in almost half of our population. Stewart et al. \[[@CR2]\] found only 12% in a smaller IM population to have any CCVD. Complex CCVDs (23% of our population, 6.3% of all patients with IM in the last 25 years) and VSDs (21% of our population, 5.6% of all patients with IM in the last 25 years) were most frequently diagnosed. Pradat et al. \[[@CR17]\] reported the co-occurrence of IM in patients with single ventricle to be as high as 8.5%. Further data on co-occurrence of CCVD in IM patients are missing.

The high prevalence of the CCVD in our IM cohort needs some thoughts on common aetiology. The gut is developed at a later stage in embryogenesis than the heart does. Abnormal abdominal development, e.g. by early development of an intra-abdominal cyst in embryogenesis, is known to enhance the chance of developing IM \[[@CR18]\]. Changes in intra-abdominal space caused by a CCVD might also increase the risk on IM development during embryogenesis \[[@CR4]\]. Another explanation might be a common genetic cause. The gut and the heart are both organs that show a characteristic left--right asymmetry, caused by a specific biochemical cascade during embryogenesis \[[@CR19]\]. Two signalling molecules inevitable for this cardiac and gastro-intestinal asymmetry are nodal and pitx2c \[[@CR20]\]. Reduced, diffuse or absent expression of pitx2c in the embryo cause abnormal looping from both heart and gut in animal studies \[[@CR21]--[@CR24]\], resulting mainly in abnormal outflow tract orientation (e.g. unseptated and misaligned great artery trunks, symmetrical outflow tract cushions, double outlet right ventricle, common atrioventricular trunk) \[[@CR23], [@CR24]\]. This disturbed expression of pitx2c could cause a spectrum of isomerism \[[@CR25]\]. More research is needed to reveal a possible common genetic cause for both CCVD and IM.

Our study group explores a high percentage of syndromes or associations. Although IM has been recognized in many syndromes and associations, this high prevalence should make us aware of co-occurrence of CCVD in these patients, as well as the possibility of a syndrome or association in patients diagnosed with both IM and CCVD. The post-operative morbidity after IM surgery in the general paediatric population is between 0 and 16.7% \[[@CR9], [@CR26]\]. A higher morbidity rate (47%) has been reported by Murphy et al. \[[@CR27]\], yet the surgical intervention was acute in 65% of their study population. Consistent with earlier reports \[[@CR6]--[@CR8]\], we found post-operative morbidity and mortality to be associated with younger age at the time of surgery. However, ischemic bowel (at the time of IM surgery) did not increase post-IM-operative morbidity as reported by others \[[@CR2], [@CR6], [@CR8], [@CR28]\]. Re-laparotomy in our population was consistent with earlier reports in the general population \[[@CR26], [@CR27]\]. The current study showed that patients with a CCVD had a relatively high morbidity rate after IM surgery (61.1%). Syndromes, associations or the presence of other congenital malformations were not found to be risk factors for post IM morbidity. Cardiovascular complications were seen in 18.1% of our population. There are neither data on prevalence of cardiovascular complications after IM surgery in the general paediatric population, nor on influence of physical condition prior to IM surgery on the morbidity after the operation. Although the type of CCVD was not significantly associated with an increased risk on morbidity, there was a clear trend (towards increased risk on post-operative morbidity) in patients with major CCVD. Furthermore, patients with pre-operative physical signs of CCVD had a high post-operative morbidity rate (77%).

The overall mortality rate in literature after IM surgery varies between 3 and 9% \[[@CR6], [@CR27]--[@CR29]\]. Ilçe et al. \[[@CR8]\] found a mortality rate varying between 0 and 36% in patients mainly younger than 1 year, having almost all emergency intervention. A recent study of Murphy et al. \[[@CR27]\] reported only 1 post-operative death in 46 patients due to cardiovascular consequences in a patient with congenital cyanotic heart disease. In the current study, the mortality rate was higher: almost one-fifth of the patients died. Patients who died were significantly younger at the time of IM surgery. Other risk factors for death were major CCVD (after correction for age and weight at the time of IM surgery), ischemic bowel at the time of IM surgery, post-IM-operative complications in general and post-IM-operative cardiovascular complications.

Diagnosis and treatment of cardiac diseases have incredibly improved in the last two decades. Associated congenital abnormalities, including IM, have increased in significance. However, since mortality rates after surgical intervention for IM in patients with an associated CCVD are high, intervention should be well thought over. Recent studies discuss the advantages of laparoscopic inspection for IM, also in acute paediatric abdomen \[[@CR30]\]. No data on laparoscopy in IM patients with CCVD are available. Possible advantages of laparoscopy for IM diagnosis, followed by operation, even in acute cases, might improve the outcome \[[@CR30]\], even in patients with major CCVD. Referral to a centre equipped with paediatric cardioanesthesiological care is imperative.

Study limitations {#Sec12}
-----------------

This is a retrospective study of all consecutive live-born IM patients referred to a single university centre over a 25-year period. There are asymptomatic IM patients who never consult a doctor. Patients with IM and a very mild CCVD might have been missed. Screening for CCVD in IM patients could give us more information on the exact prevalence of CCVD in IM patients. Furthermore, since CCVD are very common congenital defects, a prospective study on the prevalence of IM in all patients with minor and major CCVD would also be of great interest.

Each retrospective study has its limitations, e.g. some variables were not (yet) available; e.g. syndromes and associations were common in our study population. Yet, the actual prevalence of syndromes might have been higher than reported. Certain syndromes and associations are quite new and nowadays there might be more attention on searching for a fitting syndrome or association diagnosis than 20 years ago.

As regards treatment, we perform 3 years laparoscopic inspection, followed by correction of the anomaly by laparoscopy or laparotomy in very young children \[[@CR31]\].

Conclusion {#Sec13}
==========

The prevalence of CCVD in patients with IM is high (27.1%). Major and minor CCVDs are both frequently seen. Major CCVD is a risk factor for death after IM operation. Since morbidity and mortality rates in IM patients with CCVD are much higher than previously reported, a pre-operative screening for co-existing CCVD is indicated. Elective IM surgery in young patients with major CCVD should be conducted in a centre with adequate paediatric cardiac care. The benefit of laparoscopic intervention needs further follow-up.
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